SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
+2.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$1.09B
AUM Growth
+$1.09B
Cap. Flow
+$158M
Cap. Flow %
14.49%
Top 10 Hldgs %
43.03%
Holding
204
New
91
Increased
35
Reduced
20
Closed
37

Top Buys

1
SNY icon
Sanofi
SNY
$49.4M
2
ABBV icon
AbbVie
ABBV
$28.1M
3
JNJ icon
Johnson & Johnson
JNJ
$19M
4
LPSN icon
LivePerson
LPSN
$13.7M
5
AZN icon
AstraZeneca
AZN
$13.4M

Top Sells

1
NVS icon
Novartis
NVS
$40.5M
2
BMY icon
Bristol-Myers Squibb
BMY
$26.8M
3
SRPT icon
Sarepta Therapeutics
SRPT
$12.8M
4
ZYME icon
Zymeworks
ZYME
$11.6M
5
META icon
Meta Platforms (Facebook)
META
$10.9M

Sector Composition

1 Healthcare 74.93%
2 Technology 9.21%
3 Industrials 5.88%
4 Financials 3.51%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ATXS icon
76
Astria Therapeutics
ATXS
$394M
$3.74M 0.29%
+1,294,000
New +$3.74M
CYCC icon
77
Cyclacel Pharmaceuticals
CYCC
$17.2M
$3.61M 0.28%
+508,322
New +$3.61M
NKTX icon
78
Nkarta
NKTX
$149M
$3.32M 0.25%
+101,006
New +$3.32M
GRCL
79
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$3.27M 0.25%
+212,600
New +$3.27M
EWTX icon
80
Edgewise Therapeutics
EWTX
$1.54B
$3.25M 0.25%
+100,000
New +$3.25M
LVTX icon
81
LAVA Therapeutics
LVTX
$41.3M
$3.25M 0.25%
+213,894
New +$3.25M
LGV.U
82
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$3.01M 0.23%
+300,000
New +$3.01M
EUCR
83
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$3.01M 0.23%
+304,025
New +$3.01M
CLRMU
84
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$2.99M 0.23%
+300,000
New +$2.99M
GRTX
85
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.85M 0.22%
323,348
-144,314
-31% -$1.27M
GLTO icon
86
Galecto
GLTO
$3.93M
$2.72M 0.21%
448,016
+56,229
+14% +$342K
IMAB
87
I-MAB
IMAB
$380M
$2.66M 0.2%
54,962
-126,858
-70% -$6.15M
PHAS
88
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2.6M 0.2%
+750,000
New +$2.6M
ARGX icon
89
argenx
ARGX
$44.2B
$2.55M 0.2%
9,249
– –
IMVT icon
90
Immunovant
IMVT
$2.91B
$2.54M 0.2%
158,500
-11,500
-7% -$184K
SNCE
91
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.47M 0.19%
244,000
+144,000
+144% +$1.46M
FNCH
92
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.39M 0.18%
+150,000
New +$2.39M
CAMT icon
93
Camtek
CAMT
$3.51B
$2.38M 0.18%
79,746
-320,254
-80% -$9.57M
TIL icon
94
Instil Bio
TIL
$196M
$2.38M 0.18%
+95,000
New +$2.38M
INBX
95
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.3M 0.18%
114,643
+71,461
+165% +$1.43M
TMPM
96
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$2.14M 0.16%
+219,440
New +$2.14M
ALPN
97
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.1M 0.16%
198,260
– –
QSI icon
98
Quantum-Si Incorporated
QSI
$217M
$2.06M 0.16%
+172,396
New +$2.06M
WPF
99
DELISTED
Foley Trasimene Acquisition Corp.
WPF
$2.01M 0.15%
+200,000
New +$2.01M
HCAQ
100
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2M 0.15%
+200,000
New +$2M
2 3
4
5 6